Order Article Reprints

Leone MA, Mandrioli J, Russo S, Cucovici A, Gianferrari G, Lisnic V, Muresanu DF, Giuliani F, Copetti M, The Pooled Resource Open-Access ALS Clinical Trials Consortium, et al. Neutrophils-to-Lymphocyte Ratio Is Associated with Progression and Overall Survival in Amyotrophic Lateral Sclerosis. Biomedicines. 2022; 10(2):354. https://doi.org/10.3390/biomedicines10020354

Leone, Maurizio A., Jessica Mandrioli, Sergio Russo, Aliona Cucovici, Giulia Gianferrari, Vitalie Lisnic, Dafin Fior Muresanu, Francesco Giuliani, Massimiliano Copetti, The Pooled Resource Open-Access ALS Clinical Trials Consortium, and et al. 2022. "Neutrophils-to-Lymphocyte Ratio Is Associated with Progression and Overall Survival in Amyotrophic Lateral Sclerosis" Biomedicines 10, no. 2: 354. https://doi.org/10.3390/biomedicines10020354

Leone, M. A., Mandrioli, J., Russo, S., Cucovici, A., Gianferrari, G., Lisnic, V., Muresanu, D. F., Giuliani, F., Copetti, M., The Pooled Resource Open-Access ALS Clinical Trials Consortium, & Fontana, A. (2022). Neutrophils-to-Lymphocyte Ratio Is Associated with Progression and Overall Survival in Amyotrophic Lateral Sclerosis. Biomedicines, 10(2), 354. https://doi.org/10.3390/biomedicines10020354